Last reviewed · How we verify
NCT07065110
The Effect of Peroral Sodium Hyaluronate on the Skin
NA trial testing Blood draw for the laboratory assessment in Skin Conditions in 150 participants. Completed in 13 December 2024.
13 December 2024
Quick facts
| Lead sponsor | Contipro Pharma a.s. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 150 |
| Start date | 17 June 2024 |
| Primary completion | 13 December 2024 |
| Estimated completion | 13 December 2024 |
| Sites | 1 location across Czechia |
Drugs / interventions tested
- Blood draw for the laboratory assessment — full drug profile →
- Skin test panel — full drug profile →
- HA gel
- Xanthan gum
Conditions studied
- Skin Conditions — all drugs for Skin Conditions →
Sponsor
Contipro Pharma a.s. — full company profile →
Who can join
Adults 18 to 60, any sex, with Skin Conditions. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A single-center, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the superiority of peroral sodium hyaluronate to placebo in improving the skin hydration and other skin-related parameters.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Oral sodium hyaluronate improves skin hydration, barrier function and signs of aging: a randomized, double-blind, placebo-controlled trial in 150 healthy adults.
Dolečková I, Kušnierik P, Berka V, Šimek M, et al · · 2025 · PMID 41422283 · DOI 10.1038/s41598-025-32758-5
Verify or expand the search:
- PubMed search for NCT07065110
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Blood draw for the laboratory assessment
Trials testing the same drug.
- NCT07475923 — Molecular Surveillance In Early Breast Cancer Using The Tumor-Informed ctDNA Assay Myriad Genetics Precise MRD Test; A P · withdrawn
- NCT06941012 — Validation of α-synuclein Modifications in Parkinson's dIsoRder Evolution · recruiting
- NCT06905054 — Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation · Phase 2 · recruiting
- NCT06914778 — Investigating the Metabolic and Lipidomic Profiles That Are Associated With Varying Grades of Diabetic Maculopathy and R · recruiting
- NCT06865274 — Frequency of FCGR3A Gene Polymorphisms in Patients With Neuromyelitis Optica Spectrum Disorders, Anti-oligodendrocyte My · NA · recruiting
Other recruiting trials for Skin Conditions
Currently open trials in the same condition.
- NCT06202274 — Clinical Study to Evaluate the Safety and Efficacy of Candela Technology · NA · active not recruiting
Other Contipro Pharma a.s. trials
Trials by the same sponsor.
- NCT07490080 — Study With Dehisgel Used in Adult Patients Undergoing Colorectal Anastomosis · terminated
- NCT06276270 — Multi-centre, Open-label, First-in-man Study With Mucopad HA · NA · completed
- NCT05618496 — Multi-centre, Open-label, First-in-man Study With Epipad Used in Adult Patients · NA · completed
- NCT05625984 — Study With Fascigel · NA · completed
- NCT04091399 — First-in-man Study of Adult Patients Suffered From Alveolar Osteitis Treated Using Stomatological Tamponade Contipro · Phase 2 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07065110 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Contipro Pharma a.s.
- Last refreshed: 15 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07065110.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing